Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and ...
Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to ...
The tiny bits of plastic pollution that make their way from the environment into our bodies accumulate at much higher ...
Boehringer Ingelheim India has signed an MoU with EMRI Green Health Services to improve pre-hospital stroke care in India.
7h
Asian News International on MSNBoehringer Ingelheim India and EMRI Green Health Services a GVK Enterprise Sign MoU to Transform Pre-hospital Stroke Care in IndiaBoehringer Ingelheim India has signed a Memorandum of Understanding (MoU) with Hyderabad-based EMRI Green Health Services a ...
The Campaign will Donate Millions of Meals and Thousands of Doses of NexGard® PLUS (afoxolaner, moxidectin, and pyrantel ...
January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.
In an editorial, J. Mocco, MD, of Mount Sinai Health System in New York City, characterized the DISTAL and ESCAPE-MeVO ...
Brian Frank wants to run for Cincinnati mayor as a Republican. He champions outsourcing some services to save money and wants ...
Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...
21h
GlobalData on MSNSupply chains and AI take precedence at European clinical trial meetingExperts at the 2025 Clinical Trial Supply Europe will explore supply chain challenges and the impact of AI on trials.
Matthew Moll, MD, MPH, and Michael H. Cho, MD, MPH, from the Department of Medicine at Brigham and Women's Hospital are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results